Dr. Douglas has extensive laboratory experience investigating the cellular immunology of HIV/AIDS, primary immune deficiency diseases, and cellular immunopathologies. In addition, he has had significant involvement in studies related to immunological interactions.
Dr. Wood's research focuses on improving health service delivery to reduce HIV and STI incidence in adolescents and young adults. Her current projects examine improving uptake and adherence of HIV pre-exposure prophylaxis in sexual and gender minority youth, increasing STI and HIV screening in primary care, and identifying patient, neighborhood, and clinic-based barriers to HIV and sexual health service delivery.
Dr. Dowshen focuses on improving the health outcomes for adolescent and young adults (AYA) living with or at high risk for contracting HIV/AIDS and improving access and quality of care for gender expansive and transgender children and adolescents. She is particularly interested in developing and testing digital health interventions to reach, engage, and retain AYA in care.
Dr. Otero is an attending radiologist in the Division of Body Imaging with research interests in global health, health services research, genitourinary, cardiovascular, lymphatic, and pulmonary imaging.
Dr. Ma focuses on immune engineering. He leverages genetic, chemistry, and engineering tools to dissect immune cell-cell and cell-tissue crosstalk and harness these crosstalk mechanisms to develop biomaterials, protein, and cell-based precision immunotherapies for cancer and autoimmune diseases.
Dr. Walshe's research uses cognitive, neuropsychological, and neuroscientific techniques to understand higher-level cognitive control over the complex and high-risk motor task of driving. In particular, Dr. Walshe investigates how cognitive development in young drivers may impact driver safety.
Dr. Vella is an assistant professor of Pediatrics at Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine with a primary research focus on T follicular helper cells (Tfh), chronic infections, and vaccine readiness.
Dr. Jolley's research lab is focused on visualizing and quantifying congenitally abnormal heart structures using 3D imaging with the driving goal of informing surgical and interventional planning in children and adults with congenital heart disease.
Dr. Stallings is working on intervention trials involving three chronic diseases with nutrition-related abnormalities resulting in meaningful adverse outcomes: cystic fibrosis (new drugs), sickle cell disease (vitamin A) and chronic pancreatitis (enzyme replacement drug).